期刊文献+

多囊卵巢综合征不孕患者超促排卵周期中的扳机方案研究进展 被引量:3

Research Progress of Trigger Scheme in Ovarian Hyperstimulation Cycles in Infertile Women with Polycystic Ovary Syndrome
下载PDF
导出
摘要 对于多囊卵巢综合征(polycystic ovarian syndrome,PCOS)不孕患者而言,需要更优的扳机方案,获得更多的优质成熟卵母细胞、更高的妊娠率和更好的周期结局,同时降低发生卵巢过度刺激综合征(ovarian hyperstimulation syndrome,OHSS)和空卵泡综合征(empty follicle syndrome,EFS)的风险。制定扳机方案时需要考虑扳机的药物制剂、扳机时机等。人绒毛膜促性腺激素(human chorionic gonadotropin,hCG)扳机、促性腺激素释放激素激动剂(gonadotropin-releasing hormone agonist,GnRHa)扳机、亲吻素(Kisspeptin)扳机、双扳机、双重扳机等多种扳机方式在PCOS不孕患者中均有应用。梳理关于PCOS不孕患者超促排卵扳机方案的国内外文献,一方面对不同扳机方案的常用药物剂量和优缺点进行比较,另一方面对PCOS不孕患者选择扳机时机的标准进行总结,以期为临床制定PCOS扳机方案提供参考。 For infertile patients with polycystic ovary syndrome(PCOS),it is necessary to optimize the trigger scheme so as to obtain more well-matured oocytes,higher pregnancy rate and better cycle outcomes,and to reduce the incidence of ovarian hyperstimulation syndrome(OHSS)and empty follicle syndrome(empty follicle syndrome,EFS)risk.When making the trigger plan,we need to consider the drug preparation and timing of trigger.Human chorionic gonadotropin(hCG)trigger,gonadotropin-releasing hormone agonist(GnRHa)trigger,Kisspeptin trigger,dual trigger,double trigger and other trigger methods have been used in PCOS infertile patients.Based on the literature review of the ovarian hyperstimulation trigger schemes for PCOS infertile patients,the trigger drugs,dosage,advantages and disadvantages of different trigger schemes were compared in this paper,including the standard of trigger timing.These comparisons provide us a useful reference for the clinical development of PCOS personalized trigger scheme.
作者 秦一鸣 孔鑫靓 张建伟(审校) QIN Yi-ming;KONG Xin-liang;ZHANG Jian-wei(School of Traditional Chinese Medicine,Shandong University of Traditional Chinese Medicine,Jinan 250014,China;Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China;Reproductive and Genetic Center of Integrated Traditional Chinese and Western Medicine,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,China)
出处 《国际生殖健康/计划生育杂志》 CAS 2021年第3期226-230,共5页 Journal of International Reproductive Health/Family Planning
基金 山东省中医药科技发展计划(2017-072)。
关键词 多囊卵巢综合征 体外受精 排卵诱导 扳机 卵巢过度刺激综合征 Polycystic ovary syndrome Fertilization in vitro Ovulation induction Trigger Ovarian hyperstimulation syndrome
  • 相关文献

参考文献2

二级参考文献32

  • 1Escudero E, Bosch E, Crespo J, et al. Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients[J]. Fertil Steril, 2004, 81 (3):562-566.
  • 2Oberye J J, Mannaerts BM, Huisman JA, et al. Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers[J]. Fertil Steril, 1999, 72(6):1006-1012.
  • 3Huirne JA, Lambalk CB. Gonadotropin-releasing-hormone- receptor antagonists[J]. Laneet, 2001, 358(9295):1793-1803.
  • 4Copperman AB, Benadiva C. Optimal usage of the GnRH antagonists: a review of the literature[J]. Reprod Biol Endoerinol, 2013, 11:20.
  • 5Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology[J]. Cochrane Database Syst Rev, 2011(5):CD001750.
  • 6Qiao J, Lu G, Zhang HW, et al. A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates[J]. Gynecol Endocrinol, 2012, 28(10):800-804.
  • 7Marei R, Caserta D, Lisi F, et al. In vitro fertilizationstimulationprotocol for normal responder patients [J]. Gynecol Endocrinol, 2013, 29(2): 109-112.
  • 8Griesinger G, Diedrich K, Tarlatzis BC, et al. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis[J]. Reprod Biomed Online, 2006, 13(5): 628-638.
  • 9Pundir J, Sunkara SK, E1-Toukhy T, et al. Meta-analysis ofGnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?[J]. Reprod Biomed Online, 2012, 24(1):6-22.
  • 10Xiao J, Chen S, Zhang C, et al. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis[J]. Gynecol Endocrinol, 2013, 29(3): 187-191.

共引文献34

同被引文献9

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部